口服阿司匹林/氯胺酮与单用口服氯胺酮治疗急诊科急性肌肉骨骼疼痛的比较
这项前瞻性、随机、开放标签试验纳入60例急诊科18岁以上、11点数字评定量表(NRS)初始评分≥5分的中重度急性肌肉骨骼疼痛患者,随机接受口服VTS-Aspirin™ 324 mg联合氯胺酮0.5 mg/kg(AOK组)或单用口服氯胺酮0.5 mg/kg(OK组)。主要终点为给药后60分钟两组疼痛评分差异,结果为2.6(95%CI:1.38-3.77),OK组平均疼痛评分更低。AOK组60分钟疼痛评分从8.4降至6.3(差值2.1;95%CI:1.35-3.00),OK组从7.8降至3.7(差值4.1;95%CI:3.25-4.90)。两组均无严重不良事件,最常见不良事件为头晕和乏力,60分钟时无人需要补救镇痛。
要点
- 在急诊中重度急性肌肉骨骼疼痛成人中,口服阿司匹林324 mg联合氯胺酮0.5 mg/kg(AOK组)60分钟疼痛评分比单用口服氯胺酮0.5 mg/kg(OK组)高2.6分(95%CI:1.38-3.77),OK组镇痛更优。
- AOK组60分钟疼痛评分从8.4降至6.3(差值2.1;95%CI:1.35-3.00);OK组从7.8降至3.7(差值4.1;95%CI:3.25-4.90)。
- 两组均未观察到生命体征的临床相关变化,无严重不良事件,最常见不良事件为头晕和乏力。
- 给药后60分钟时,两组均无患者需要补救镇痛。
适用人群与场景
- 急诊科18岁及以上、表现为中重度急性肌肉骨骼疼痛的成人患者,疼痛由11点数字评定量表(NRS)定义,初始评分≥5分。
诊断标准与关键阈值
- 急性肌肉骨骼疼痛采用11点数字评定量表(NRS)评估,初始评分≥5分定义为中重度疼痛。
处置流程与药物剂量
- AOK组:口服VTS-Aspirin™ 324 mg联合口服氯胺酮0.5 mg/kg,直接吞服。
- OK组:口服氯胺酮0.5 mg/kg,先漱口再吞服。
- 在基线、30、60、90、120分钟进行评估。
研究设计与关键结果
- 研究类型:前瞻性、随机、开放标签试验;样本量60例(每组30例);人群:急诊科18岁及以上、NRS初始评分≥5分的中重度急性肌肉骨骼疼痛成人。
- 干预与对照:AOK组(口服VTS-Aspirin™ 324 mg联合氯胺酮0.5 mg/kg,直接吞服) vs OK组(口服氯胺酮0.5 mg/kg,先漱口再吞服)。
- 主要终点:给药后60分钟两组平均疼痛评分差异为2.6(95%CI:1.38-3.77),OK组平均疼痛评分更低。
- 关键次要终点:AOK组60分钟疼痛评分从8.4降至6.3(差值2.1;95%CI:1.35-3.00);OK组从7.8降至3.7(差值4.1;95%CI:3.25-4.90)。
- 不良事件:两组均无严重不良事件,未观察到生命体征的临床相关变化;最常见不良事件为头晕和乏力。
- 补救镇痛:给药后60分钟时,无参与者需要补救镇痛。
证据类型、等级与局限
- 证据类型:前瞻性、随机、开放标签试验。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,对于急诊科中重度急性肌肉骨骼疼痛的短期治疗,口服VTS-Aspirin™联合氯胺酮的镇痛效果弱于单用口服氯胺酮。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVE: The purpose of this study is to investigate if an orally administered combination of aspirin and ketamine will provide better analgesia than a ketamine alone in adult patients presenting to the Emergency Department (ED) with acute musculoskeletal pain.
METHODS: We conducted a prospective, randomized, open-label trial of ED patients aged 18 and older presenting with moderate to severe acute musculoskeletal pain as defined by an 11-point numeric rating scale (NRS) with an initial score of ≥5. Patients were randomized to receive either 324 mg of VTS-Aspirin™ and 0.5 mg/kg of oral ketamine (AOK) that is directly swallowed or 0.5 mg/kg of oral ketamine (OK) alone that is swished first and then swallowed. Patients were assessed at baseline, 30, 60, 90, and 120 min. The primary outcome was a difference in pain scores between the two groups at 60 min post-administration. Secondary outcomes included adverse events and the need for rescue analgesia.
RESULTS: We enrolled 60 patients in the study (30 per group). The difference in mean pain scores at 60 min between the AOK and OK groups was 2.6 [95% CI: 1.38-3.77] showing a lower mean pain score in the OK group. At 60 min, the AOK group had a change in mean pain score from 8.4 to 6.3 (difference 2.1; 95% CI: 1.35-3.00). The OK group had a change in mean pain score from 7.8 to 3.7 (difference 4.1, 95% CI: 3.25-4.90). No clinically concerning changes in vital signs were observed. No serious adverse events occurred in either group. The most commonly reported adverse effects were dizziness and fatigue. None of the participants required rescue analgesia at 60 min post-medications administration.
CONCLUSION: The administration of an oral combination of VTS-Aspirin ™ and ketamine resulted in less analgesia compared to oral ketamine alone, for the short-term treatment of moderate to severe acute musculoskeletal pain in the ED.
CLINICALTRIALS: govRegistration: NCT04860804.
参考来源
- Gerges L, Fassassi C, Barberan C, et al. Oral Aspirin/ketamine versus oral ketamine for emergency department patients with acute musculoskeletal pain. Am J Emerg Med. 2022. PMID: 35777275. doi:10.1016/j.ajem.2022.05.026
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。